Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Evogene Ltd (NYSE:EVGN)

6.86
Delayed Data
As of 9:33am ET
 +0.27 / +4.10%
Today’s Change
5.93
Today|||52-Week Range
9.46
-14.78%
Year-to-Date
No recent news for Evogene Ltd.

Today’s Trading

Previous close6.59
Today’s open6.83
Day’s range6.81 - 6.86
Volume2,318
Average volume (3 months)5,319
Market cap$167.7M
Dividend yield--
Data as of 9:33am ET, 07/27/2016

Growth & Valuation

Earnings growth (last year)-17.24%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-23.31%
P/E ratio--
Price/Sales18.24
Price/Book1.61

Competitors

 Today’s
change
Today’s
% change
PIPPharmAthene Inc-0.00-0.10%
OSIROsiris Therapeutics ...+0.04+0.80%
BPTHBio Path Holdings In...+0.04+2.37%
QUREUniqure NV+0.01+0.14%
Data as of 12:06pm ET, 07/27/2016

Financials

Next reporting dateAugust 11, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$11.1M
Annual profit (last year)-$17.2M
Net profit margin-154.67%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ofer Haviv
Chief Operating Officer
Assaf Kacen
Corporate headquarters
Rehovot, Tel Aviv

Forecasts

Partner Offers

Search for Jobs